Player FMアプリでオフラインにしPlayer FMう!
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D
Manage episode 414022686 series 2908385
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication.
(00:32)
Could you provide us with a little bit of information about yourself and your background?
(01:18)
Can you start with a brief overview of the assay?
(02:13)
Which patients should have this testing and when should it be performed?
(03:21)
Are there alternative test options available and how do those compare with the folate receptor alpha assay?
(03:57)
How are the results used in patient care?
330 つのエピソード
Manage episode 414022686 series 2908385
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication.
(00:32)
Could you provide us with a little bit of information about yourself and your background?
(01:18)
Can you start with a brief overview of the assay?
(02:13)
Which patients should have this testing and when should it be performed?
(03:21)
Are there alternative test options available and how do those compare with the folate receptor alpha assay?
(03:57)
How are the results used in patient care?
330 つのエピソード
すべてのエピソード
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。